Legend Biotech Corp ADR (NASDAQ: LEGN) is -8.92% lower on its value in year-to-date trading and has touched a low of $48.20 and a high of $77.32 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LEGN stock was last observed hovering at around $54.93 in the last trading session, with the day’s loss setting it -0.13%.
Currently trading at $54.80, the stock is -8.76% and -9.33% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.66 million and changing -0.24% at the moment leaves the stock -15.07% off its SMA200. LEGN registered 13.76% gain for a year compared to 6-month loss of -16.41%. The firm has a 50-day simple moving average (SMA 50) of $31.52 and a 200-day simple moving average (SMA200) of -$18.81.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -14.67% gain in the last 1 month and extending the period to 3 months gives it a -2.91%, and is -4.23% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.18% over the week and 4.72% over the month.
Legend Biotech Corp ADR (LEGN) has around 1826 employees, a market worth around $9.97B and $285.14M in sales. Profit margin for the company is -181.75%. Distance from 52-week low is 13.69% and -29.13% from its 52-week high. The company has generated returns on investments over the last 12 months (-32.87%).
Legend Biotech Corp ADR quarterly earnings per share for the current quarter are estimated at -$0.34 with sales reaching $164.15M over the same period.The EPS is expected to grow by 22.65% this year, but quarterly earnings will post 109.50% year-over-year. Quarterly sales are estimated to grow 351.80% in year-over-year returns.
Legend Biotech Corp ADR (LEGN) Top Institutional Holders
337 institutions hold shares in Legend Biotech Corp ADR (LEGN), with institutional investors hold 49.34% of the company’s shares. The shares outstanding are 181.91M, and float is at 180.13M with Short Float at 5.83%. Institutions hold 48.71% of the Float.
The top institutional shareholder in the company is FMR, LLC with over 17.05 million shares valued at $1.18 billion. The investor’s holdings represent 10.33% of the LEGN Shares outstanding. As of Jun 29, 2023, the second largest holder is Price (T.Rowe) Associates Inc with 9.03 million shares valued at $623.43 million to account for 5.47% of the shares outstanding. The other top investors are HHLR Advisors, LTD which holds 6.44 million shares representing 3.90% and valued at over $444.31 million, while RA Capital Management, L.P. holds 3.80% of the shares totaling 6.26 million with a market value of $432.45 million.
